• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cytodyn Inc (OP: CYDY )

    0.1176 -0.0036 (-2.97%)
    Streaming Delayed Price Updated: 2:35 PM EST, Nov 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Cytodyn Inc

    Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
    On December 14th, the Federal Reserve hiked its key interest rate by 50 basis points. This was the first deceleration in rate hike increases in 2022; between March and November 2022, the interest rate... 
    Via Benzinga
    OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes
    The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 5.56% in November, recording two subsequent monthly increases for the first time in 2022. 
    Via Benzinga
    Most Active On The OTC Markets In September – A Look Back As October Comes To A Close
    The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) declined by 9.62% in September – its largest decline in 2022. 
    Via Benzinga
    OTC Markets' Most Active Securities Sees A Shake-up In July
    July gave world markets a breather from 2022’s poor financial conditions. 
    Via Benzinga
    These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
    The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share... 
    Via Benzinga
    Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
    Reflecting the expected conditions of a bear market, many of the world’s indices saw a decrease in price throughout June. 
    Via Benzinga
    The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
    Photo from Jason Briscoe on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
    Via Benzinga
    Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
    Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The... 
    Via Benzinga
    These OTC Markets Securities had the Most Trading Activity in September
    Photo by Annie Spratt on Unsplash As the 3rd quarter came to a close in September, the OTC Markets saw a slight decrease in total trading volume even as companies reported... 
    Via Benzinga
    The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities
    Photo by Kyrie Kim on Unsplash In a similar vein to 2020, the market’s volatility to start 2021 gave way to less volatility in the second quarter, and even less volatility... 
    Via Benzinga
    The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
    Via Benzinga
    What's Behind This Wild-Card Coronavirus Stock?
    Failure is not an option for this small-cap biotech developing a COVID-19 treatment. 
    Via The Motley Fool
    Exposures COVID-19
    CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines
    After facing rebuke from FDA, CytoDyn Inc (OTC: CYDY) plans to submit the topline results of its CD12 Phase 3 trial of Vyrologix (leronlimab-PRO 140... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    CytoDyn Stock Falls After FDA Rebukes Claims On COVID-19 Treatment
    The FDA has accused CytoDyn Inc (OTC: CYDY) of trying to pick and choose data from two failed studies of leronlimab in COVID-19 patients to claim the drug is... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    These OTC Securities Had the Most Trading Activity in April
    April was another fascinating month in OTC Markets trading, as cryptocurrency, internatio... 
    Via Benzinga
    The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc... 
    Via Benzinga
    Exposures COVID-19
    Review Of Present Therapies For Covid-19
    A summary of authorized drugs for Covid-19, those in development, and those that have failed. 
    Via Talk Markets
    Exposures COVID-19
    Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today
    Auris Medical Holding Ltd. (NASDAQ: EARS), CytoDyn Inc. (OTC: CYDY) and Prometheus Biosciences, Inc. (NASDAQ: RXDX) are among the biggest movers in the biopharma space Thursday.... 
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.